Industry Analysis & Industry Trends
The Veterinary Pharmaceutical Manufacturing industry is a relatively small segment of the general Australian pharmaceutical sector. The industry is involved in the development and manufacture of animal health products including veterinary medicines, vaccines, and other biological and medicinal feed additives. As such, it is geared towards two main segments: food producing animals (including cattle, pigs, poultry and sheep) and companion animals (including cats and dogs). In 2011-12, the industry accounted for just 4.4% of the overall pharmaceutical industry.
Over the five years through 2013-14, the performance of the industry was highly volatile as it contended with a number of external shocks... purchase to read more
Industry Report - Industry Investment Chapter
Like the rest of the pharmaceutical product manufacturing sector, this industry has a medium level of capital intensity. This reflects that capital is a core component in developing sophisticated veterinary pharmaceutical goods, with products often manufactured in world-class, high-cost production facilities using high-tech processes.
Simultaneously the industry also relies heavily on the use of high-skill labour to develop and manufacture its products. For every dollar spent on capital expenses, $8.02 is spent on labour. The high skilled nature of the industry's labour force reflects its use of dangerous or toxic chemicals that could be fatal if incorrectly prepared... purchase to read more